ScinoPharm to Invest in Tanvex Biologics
pharmaceutical ingredient (API) developer and manufacturer headquartered in
was in the form of tangible assets, intellectual properties, as well as cash.
Tanvex specializes in the development of biosimilars and biobetters, as
well as the provision of contract research and contract manufacturing services
for biologics. The company is currently establishing a cGMP facility in
Tanvex is founded by Dr.
Executive Officer of Watson Pharmaceuticals, Inc.
will become the Chief Executive Officer of Tanvex. Dr. Chao will remain as
Executive Chairman of Tanvex.
About ScinoPharm Taiwan
ScinoPharm Taiwan, Ltd. is a leading process R&D and API manufacturing
service provider to the global pharmaceutical industry. With research and
manufacturing facilities in both
a wide portfolio of services ranging from custom synthesis for early phase
pharmaceutical activities to brand companies as well as APIs for the generic
industry. For more information, please visit http://www.scinopharm.com .
About Tanvex Biologics
Tanvex Biologics, LLC is a US-based biopharmaceutical company specializing
in the development of biopharmaceuticals.
Media Contact: ScinoPharm Taiwan, Ltd. Sabrian Wu Tel: +886-6-505-2869 Mobile Phone: +886-920-056-385 Email: email@example.com
SOURCE ScinoPharm Taiwan, Ltd.